This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: A 3-Week, Open Label Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Extended Release Seroquel XR in the Treatment of Agitation in Patients with Schizophrenia, Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, January 2013, ScopeMed International Medical Journal Management and Indexing System,
DOI: 10.5455/bcp.20130127022922.
You can read the full text:
The following have contributed to this page
